Tuesday, December 6, 2022
wellness India Expo
Home Tags Manufacturing

Tag: Manufacturing

7th advanced GMP workshop by IPA to strengthen manufacturing practices &...

The workshops help improve the understanding on core issues such as quality management, global best practices, and new technologies in manufacturing

Trivitron sets up its Centre-of-Excellence in R&D & manufacturing on AMTZ...

The new centre of Trivitron will have provision to manufacture 300 million RT-PCR tests and over 70 million tests of Rapid Card/POCT per annum

Baxter Pharmaceuticals India celebrates 5 years of operations in Ahmedabad

The Baxter Ahmedabad facility is a cutting-edge generic injectables manufacturing facility that produces essential generic medicines

Merck India’s 3rd Annual Pharma Forum 2022 to be held in...

The event scheduled on 10th August is focused on shaping the next gen processing of pharma manufacturing

IIT Guwahati establishes CoE to develop health-tech for last-mile population

As per Prof. T.G. Sitharam, Director, IIT Guwahati, Centre is working towards achieving the goals of ‘Atmanirbhar Bharat’ in the domain of healthcare technology development

Indian Immunologicals to expand New Zealand operations

Company's subsidiary Pristine Biologicals NZ inaugurated New Sterile Filtered Serum manufacturing facility in Dargaville, New Zealand

Philips expands its medical devices manufacturing & R&D facility in Pune

Philips also announces the acquisition of 10 acres of land to build a new R&D center to expand Innovation capabilities in Pune to invest further in India

Trivitron Healthcare sets up a new ultrasound manufacturing facility in India

The new manufacturing facility of Trivitron Healthcare will be manufacturing a wide range of advanced ultrasound devices and accessories

Novartis India extends access to its medicines in India by signing...

The arrangement brings together the manufacturing and development synergies of Novartis India Limited with the sales and distribution strengths of Dr. Reddy’s Laboratories

Pact signed to manufacture anti-COVID drug 2-DG

Studies have shown that the anti-COVID oral drug 2- DG has resulted in quick recovery and reduction in oxygen dependence among moderately and severely affected patients..................